Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
Georgetown University
· 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
nivolumab
triple-negative-breast-cancer
triple negative breast cancer, nivolumab, capecitabine, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
#1048144
Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)
#1048145
Magic Camp for Children With Hemiplegic Cerebral Palsy
#1048147
Impact of Different Restorative Treatments for Deep Caries Lesion in Primary Teeth
#1048148
Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty
#1048152
Record
· ID 812322
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.